AstraZeneca looks to EU decision for next cancer drug boost
October 14, 2014 at 09:02 AM EDT
* EU agency to decide on olaparib in ovarian cancer next week
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.